This study aimed to determine the molecular characterization and subtype distribution of Blastocystis sp. isolated from cancer children and adolescents in Shiraz, Fars province, southwestern Iran.
Overall, 200 fecal samples obtained from cancer children and adolescents under 18 years old (107 males and 93 females) and checked by microscopy, culture, and molecular methods (PCR). Possible etiological factors and clinical characteristics of Blastocystis infection were also evaluated and compared between Blastocystis infected and non-infected patients.
Thirteen of 200 (6.5%) stool samples were positive for Blastocystis by microscopy. While 21 of 200 (10.5%) were positive by culture, and 24 of 200 (12%) were positive by PCR. Out of 24 positive samples tested by PCR and sequencing, ST3 was reported as the most common subtype (nine samples, 37.5%), followed by ST2 (eight samples, 33.3%), ST1 (five samples, 20.9%), and ST7 (two samples, 8.3%). The prevalence of Blastocystis infection in males was significantly higher than females (p = 0.024). Also, Blastocystis was more prevalent in patients who had received at least eight chemotherapy cycles than fewer (p = 0.002). However, no associations were found between Blastocystis-positive rate and age, residence, type of cancers, or contact with animals. Also, there was no significant difference between frequency of Blastocystis subtypes in symptomatic and asymptomatic cancer patients.
Various controlled epidemiologic and topographic studies need to confirm or reject these possible associations with Blastocystis infection. The data from this study are an invaluable addition to the growing body of research studies on Blastocystis infection in cancer patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Scanlan PD (2012) Blastocystis: past pitfalls and future perspectives. Trends Parasitol 28:327–334
Clark CG, van der Giezen M, Alfellani MA, Stensvold CR (2013) Recent developments in Blastocystis research. Adv Parasitol 82:1–32
Forsell J, Bengtsson-Palme J, Angelin M, Johansson A, Evengård B, Granlund M (2017) The relation between Blastocystis and the intestinal microbiota in Swedish travellers. BMC Microbiol 17:231
Khademvatan S, Masjedizadeh R, Yousefi-Razin E, Mahbodfar H, Rahim F, Yousefi E, Foroutan M (2018) PCR-based molecular characterization of Blastocystis hominis subtypes in southwest of Iran. J Infect Public Health 11:43–47
Li LH, Zhou XN, Du ZW, Wang XZ, Wang LB, Jiang JY et al (2007) Molecular epidemiology of human Blastocystis in a village in Yunnan province, China. Parasitol Int 56:281–286
Leelayoova S, Siripattanapipong S, Thathaisong U, Naaglor T, Taamasri P, Piyaraj P, Mungthin M (2008) Drinking water: a possible source of Blastocystis spp. subtype 1 infection in schoolchildren of a rural community in central Thailand. Am J Trop Med Hyg 79(3):401–406
Silberman JD, Sogin ML, Leipe DD, Clark CG (1996) Human parasite finds taxonomic home. Nature 380:398
Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21:639–665
Stensvold CR, Clark CG (2016) Current status of Blastocystis: a personal view. Parasitol Int 65(6):763–771
Cian A, El Safadi D, Osman M, Moriniere R, Gantois N, Benamrouz-Vanneste S, Delgado-Viscogliosi P, Guyot K, Li LL, Monchy S, Noël C (2017) Molecular epidemiology of Blastocystis sp. in various animal groups from two French zoos and evaluation of potential zoonotic risk. PLoS One 12(1):e0169659
Ramírez JD, Sánchez A, Hernández C, Flórez C, Bernal MC, Giraldo JC, Reyes P, López MC, García L, Cooper PJ, Vicuña Y (2016) Geographic distribution of human Blastocystis subtypes in South America. Infect Genet Evol 41:32–35
Stensvold CR (2013) Blastocystis: genetic diversity and molecular methods for diagnosis and epidemiology. Trop Parasitol 3:26
Parkar U, Traub RJ, Kumar S, Mungthin M, Vitali S, Leelayoova S, Morris K, Thompson RC (2007) Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology 134:359–367
Stensvold CR, Arendrup MC, Jespersgaard C, Mølbak K, Nielsen HV (2007) Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis 59:303–307
Wawrzyniak I, Poirier P, Viscogliosi E, Dionigia M, Texier C, Delbac F, Alaoui HE (2013) Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis 1:167–178
Puthia MK, Lu J, Tan KS (2008) Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-κB-dependent manner. Eukaryot cell 7:435–443
Chandramathi S, Suresh KG, Mahmood AA, Kuppusamy UR (2010) Urinary hyaluronidase activity in rats infected with Blastocystis hominis evidence for invasion? Parasitol Res 106(6):1459–1463
Santos HL, Sodré FC, de Macedo HW (2014) Blastocystis sp. in splenic cysts: causative agent or accidental association? A unique case report. Parasit Vectors 7(1):207
Idris NS, Dwipoerwantoro PG, Kurniawan A, Said M (2010) Intestinal parasitic infection of immunocompromised children with diarrhoea: clinical profile and therapeutic response. J Infect Dev Ctries 4:309–317
Mirza H, Teo JD, Upcroft J, Tan KS (2011) A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 55(2):637–648
Dullaert-de Boer M, Schuurs TA, Vermeer M, Ruijs GJ, van der Zanden AG, Weel JF, van Coppenraet LE (2020) Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study. Eur J Clin Microbiol Infect Dis 39(1):197–203
Klastersky J, Aoun M (2004) Opportunistic infections in patients with cancer. Ann Oncol 15:329–335
Yersal O, Malatyali E, Ertabaklar H, Oktay E, Barutca S, Ertug S (2016) Blastocystis subtypes in cancer patients: analysis of possible risk factors and clinical characteristics. Parasitol Int 65:792–796
Solomayer EF, Feuerer M, Bai L, Umansky V, Beckhove P, Meyberg GC, Bastert G, Schirrmacher V, Diel IJ (2003) Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res 9:174–180
Kumarasamy V, Kuppusamy UR, Samudi C, Kumar S (2013) Blastocystis sp. subtype 3 triggers higher proliferation of human colorectal cancer cells, HCT116. Parasitol Res 112(10):3551–3555
Zhang W, Ren G, Zhao W, Yang Z, Shen Y, Sun Y, Liu A, Cao J (2017) Genotyping of Enterocytozoon bieneusi and subtyping of Blastocystis in cancer patients: relationship to diarrhea and assessment of zoonotic transmission. Front Microbiol 8:1835
Chandramathi S, Suresh K, Anita ZB, Kuppusamy UR (2012) Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg 106:267–269
Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, Livrelli V (2011) Development and evaluation of a real-time PCR assay for detection and quantification of Blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol 49(3):975–983
Tan TC, Ong SC, Suresh KG (2009) Genetic variability of Blastocystis sp. isolates obtained from cancer and HIV/AIDS patients. Parasitol Res 105(5):1283
Mohamed AM, Ahmed MA, Ahmed SA, Al-Semany SA, Alghamdi SS, Zaglool DA (2017) Predominance and association risk of Blastocystis hominis subtype I in colorectal cancer: a case control study. Infect Agents Cancer 12:21
Horiki N, Kaneda Y, Maruyama M, Fujita Y, Tachibana H (1999) Intestinal blockage by carcinoma and Blastocystis hominis infection. Am J Trop Med Hyg 60:400–402
Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, Bouzbid S, Hamdi-Cherif M (2017) International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol 18:719–731
Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841
Raihala J, Riikonen P, Kekalainem L, Perkkiφ M (2000) Cost analysis of the treatment of acute childhood lymphocytic leukemia according to the Nordic protocols. Acta Paediatr 89:482–487
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics, 2014. CA 64(2):83–103
Magrath I (1997) Pediatric oncology in countries with limited resources. Princ Pract Pediatr Oncol 1997:1395–1420
Chan KH, Chandramathi S, Suresh K, Chua KH, Kuppusamy UR (2012) Effects of symptomatic and asymptomatic isolates of Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res 110:2475–2480
Santín M, Gómez-Muñoz MT, Solano-Aguilar G, Fayer R (2011) Development of a new PCR protocol to detect and subtype Blastocystis spp. from humans and animals. Parasitol Res 109(1):205–212
Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Sympos Ser 41:95–98
Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549
Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696–704
Ronquist F, Huelsenbeck JP (2003) MrBayes 3: bayesian phylogenetic inference under mixed models. Bioinformatics 19:1572–1574
Posada D (2008) jModelTest: phylogenetic model averaging. Mol Biol Evol 25(7):1253–1256
Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791
Kimura M (1980) A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120
Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044
Mohammad NA, Mastuki MF, Al-Mekhlafi HM, Moktar N, Anuar TS (2018) Comparative study of wheatley’s trichrome stain and in-vitro culture against PCR assay for the diagnosis of Blastocystis sp. in stool samples. Iran J Parasitol 13(1):127
Roberts T, Barratt J, Harkness J, Ellis J, Stark D (2011) Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of Blastocystis sp. in clinical stool samples. Am J Trop Med Hyg 84(2):308–312
Stensvold CR, Ahmed UN, Andersen LO, Nielsen HV (2012) Development and evaluation of a genus-specific, probe-based, internal-process-controlled real-time PCR assay for sensitive and specific detection of Blastocystis spp. J Clin Microbiol 50(6):1847–1851
Stensvold CR, Suresh GK, Tan KS, Thompson RA, Traub RJ, Viscogliosi E, Yoshikawa H, Clark CG (2007) Terminology for Blastocystis subtypes a consensus. Trends Parasitol 23:93–96
Asghari A, Sadraei J, Pirestani M, Mohammadpour I (2019) First molecular identification and subtype distribution of Blastocystis sp. isolated from hooded crows (Corvus cornix) and pigeons (Columba livia) in Tehran Province Iran. Compar Immunol Microbiol Infect Dis 1(62):25–30
Wong KH, Ng CG, Lin RT, Yoshikawa H, Taylor MB, Tan KS (2008) Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res 102:663–670
Tan KS, Mirza H, Teo JD, Wu B, MacAry PA (2010) Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep 12:28–35
Salehi R, Haghighi A, Stensvold CR, Kheirandish F, Azargashb E, Raeghi S, Kohansal C, Bahrami F (2017) Prevalence and subtype identification of Blastocystis isolated from humans in Ahvaz, Southwestern Iran. Gastroenterol Hepatol Bed Bench 10:235
Khoshnood S, Rafiei A, Saki J, Alizadeh K (2015) Prevalence and genotype characterization of Blastocystis hominis among the baghmalek people in southwestern Iran in 2013–2014. Jundishapur J Microbiol 8(10):e23930
Javanmard E, Niyyati M, Ghasemi E, Mirjalali H, Aghdaei HA, Zali MR (2018) Impacts of human development index and climate conditions on prevalence of Blastocystis: a systematic review and meta-analysis. Acta tropica 185:193–203
İnceboz T, Usluca S, Leyla ÖV, Yalçin G, Tuncay S, Özkoç S (2011) The epidemiology research of Blastocystis hominis in the Dokuz Eylül University Medical Faculty Hospital between 2005 and 2009. Türkiye Parazitolojii Dergisi. 35(2):72
Eassa SM, Masry SA (2016) Blastocystis hominis among Immunocompromised and Immunocompetent Children in Alexandria Egypt. Ann Clin Lab Res 4:92
Devera R, Azacon B, Jimenez M (1998) Blastocystis hominis in patients at the Ruiz y Paez University hospital from Bolivar City. Venezuela Boletin chileno de parasitologia 53:65–70
Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P (2014) Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome. Scand J Infect Dis 46:204–209
Minvielle MC, Pezzani BC, Cordoba MA, De Luca MM, Apezteguia MC, Basualdo JA (2004) Epidemiological survey of Giardia spp. and Blastocystis hominis in an Argentinian rural community. Korean J Parasitol 42(3):121
Doyle PW, Helgason MM, Mathias RG, Proctor EM (1990) Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol 28:116–121
Wang KX, Li CP, Wang J, Cui YB (2002) Epidemiological survey of Blastocystis hominis in Huainan city, Anhui province China. World J Gastroenterol 8:928
Moosavi A, Haghighi A, Mojarad EN, Zayeri F, Alebouyeh M, Khazan H, Kazemi B, Zali MR (2012) Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res 111(6):2311–2315
Tasova Y, Sahin B, Koltas S, Paydas S (2000) Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Medica Okayama 54:133–136
Hussein EM, Hussein AM, Eida MM, Atwa MM (2018) Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 102:853–860
Özyurt M, Kurt Ö, Mølbak K, Nielsen HV, Haznedaroglu T, Stensvold CR (2008) Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int 57(3):300–306
Dogruman-Al F, Yoshikawa H, Kustimur S, Balaban N (2009) PCR-based subtyping of Blastocystis isolates from symptomatic and asymptomatic individuals in a major hospital in Ankara Turkey. Parasitol Res 106:263–268
Souppart L, Sanciu G, Cian A, Wawrzyniak I, Delbac F, Capron M, Dei-Cas E, Boorom K, Delhaes L, Viscogliosi E (2009) Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res 105:413
The authors thank the Vice Chancellor for Research of Shiraz University of Medical Sciences for the financial support of this study.
Conflict of interest
The authors declare that they have no conflict of interest.
All stages of the present study were confirmed by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Fars province, Iran (Approval no: IR.SUMS.REC.1398.266).
Informed consent was obtained from all individual participants included in the study (parents of patients).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Asghari, A., Zare, M., Hatam, G. et al. Molecular identification and subtypes distribution of Blastocystis sp. isolated from children and adolescent with cancer in Iran: evaluation of possible risk factors and clinical features. Acta Parasit. 65, 462–473 (2020). https://doi.org/10.2478/s11686-020-00186-2
- Blastocystis sp.